Skip to main content
Market intelligence
ROIVHealthcare

Roivant Sciences Ltd insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 15, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 15, 2026Melissa B EpperlyCorporate insiderSale4,938$39.74$196,230
Sep 15, 2026Meghan FitzgeraldCorporate insiderSale5,112$39.74$203,152
Sep 8, 2026Meghan FitzgeraldDirectorSale20,000$39.90$798,000